Treatment: Treatment used as an experimental variable in a series of experiments.
TreatmentDescriptionLabel
diffProtA_9d H7 embryoid bodies differentiation protocol for cardiomyocyte, endothelial, smooth muscle, with markers cardiac troponin T (cTnT), CD31/PECAM1, smooth muscle alpha actin (SMA), respectively, using proteins from bone morphogenic protein 4 (BMP4), activin A and basic fibroblast growth factor (bFGF) for 9 days, lineage: mesoderm 9 day diff protocol A